SCAR1 Antibody

Introduction to SCAR1 Antibody

SCAR1 antibodies recognize SCAR/WAVE1, a conserved actin-nucleating protein essential for lamellipodia formation, cell motility, and cytokinesis . These antibodies are widely used across species, including Drosophila melanogaster, Dictyostelium, and mammals .

Actin Dynamics

• SCAR1 activates Arp2/3-mediated actin polymerization, enabling lamellipodia formation in migrating cells .

• Deletion of the N-terminal 96 amino acids disrupts SCAR1’s interaction with regulatory complexes (e.g., Abi, HSPC300), leading to cytoskeletal defects .

Cellular Roles

• Cell Motility: SCAR1-deficient cells exhibit impaired chemotaxis and aberrant F-actin distribution .

• Immune Function: SCAR1 indirectly influences innate immunity by modulating macrophage activity and complement recruitment .

Research Applications

SCAR1 antibodies are validated for multiple techniques:

Comparative Antibody Performance

Commercial SCAR1 antibodies vary in specificity and utility:

IF = Immunofluorescence; IP = Immunoprecipitation; WB = Western Blot; IHC = Immunohistochemistry

Genetic Knockouts

• Dictyostelium ΔSCAR1: Shows defective F-actin distribution, increased adhesion, and impaired cytokinesis .

• Mouse SCAR1−/−: Reduces IgM and C3 complement recruitment to injured muscle, exacerbating fibrosis .

Therapeutic Implications

• Vascular Restenosis: Anti-Sca-1 antibodies reduce CD34+/c-kit+ progenitor cell surges, mitigating post-injury vascular remodeling .

• Cancer Metastasis: SCAR1 dysregulation correlates with altered cell migration in breast cancer models .

Limitations and Considerations

• Species Specificity: Some clones (e.g., EPR15021) show reactivity only in humans .

• Stability: Truncated SCAR1 mutants (e.g., Δ96) evade degradation, complicating functional studies .